Skip to main content

Data Explorer

Research historical outbreak investigations and the full recall archive, with charts, trends, and advanced filters. Looking for what's happening right now instead? See current Health Alerts.

Recall totals

All FDA and USDA recalls in Public Health Trace, June 2012 to September 2026.

37,063
Total recall recordsAll FDA and USDA recalls in Public Health Trace
9,786
Class I recallsReasonable probability of serious health consequences
24,313
Class II recallsTemporary or medically reversible health consequences
2,876
Class III recallsNot likely to cause adverse health consequences

Quick insights

A snapshot of the most notable patterns across all recorded FDA and USDA recalls.

Most recalled product100 vegetarian Fenugreek Capsules 90 count, 600mg, packaged in 150cc Amber Glass Packer with White Polypropylene Cap. 53 recalls
Most common hazardLack of Assurance of Sterility 2,072 recalls
Most affected stateHawaii 200 recalls mention this state

Download matching recalls as CSV

CSV exports include up to 5,000 matching rows (applying your current filters), not the full dataset if it's larger.

Filters
Recall details
Location
Date range
Sort results
Clear filters
Metric
View
Recalls announced by month (Year to date)

A chart of recalls grouped by month.

Download CSV

Source: FDA and USDA public dataLast updated

Summary (Year to date)

  • 1,527 recalls have been announced year to date.
  • Aug 2026 was 24% lower than the previous complete period (Jul 2026: 240).
  • The highest complete period was Jun 2026 (297).
  • Sep 2026 is incomplete and not included in the figures above.
  • Complete data
  • Incomplete
Recalls by class

A bar chart of the total number of recalls in this dataset by recall class.

Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2
Download CSV
Recalls by class
ClassRecalls
Class II24,313
Class I9,786
Class III2,876
Not Yet Classified2

Showing 2,641–2,660 of 17,299 recalls

FDA Recall Terminated Historical recordClass II

midazolam in dextrose 5%, 50 mg/50 mL, (1 mg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-4036-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL 2 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2082-2

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL 2 mcg/mL and bupivacaine 0.0625% PF in 0.9% sodium chloride, Total Volume = 250 mL, Total fentaNYL 500 mcg/250 mL, 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2081-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL 1.5 mcg/mL and bupivacaine 0.125% PF in 0.9% sodium chloride / Total Volume = 50 mL, Total fentaNYL 75 mcg/50 mL, 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2080-2

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 5,000 mcg/250 mL, (20 mcg/mL), 250 mL Bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2074-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 2,500 mcg/250 mL, (10 mcg/mL), 250 mL bag, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-5

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 1,000 mcg/100 mL, (10 mcg/mL), 100 mL bag, Rx only, CAPS, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-4

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 500 mcg/50 mL, (10 mcg/mL), 50 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-3

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 100 mcg/10 mL, (10 mcg/mL), 10 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-2071-2

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C San Diego, CA 92126, NDC: 71286-2071-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

rocuronium, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6010-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

PHENYLephrine in 0.9% sodium chloride, 1,000 mcg/10 mL, (100 mcg/mL), 10 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6009-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

PHENYLephrine in 0.9 sodium chloride, 800 mcg/10 mL, (80 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6008-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

PHENYLephrine in 0.9 sodium chloride, 400 mcg/10 mL, (40 mcg/mL), 10 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6007-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

lidocaine 2%, 100 mg/5 mL, (20 mg/mL), 5 mL Syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC: 71286-6006-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ePHEDrine in 0.9% sodium chloride, 50 mg/5 mL, (10 mg/mL), 5 mL Syringe, Rx only, CAPS Inc., Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-6004-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

ketamine in 0.9% sodium chloride, 50 mg/5mL (10mg/mL), 5 mL syringe, Rx only, CAPS, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-3022-1

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass II

fentaNYL in 0.9% sodium chloride, 10 mcg/1 mL, (10 mcg/mL), 3 mL syringe, Rx only, Central Admixture Pharmacy Services, Inc., 7935 Dunbrook Road, Suite C, San Diego, CA 92126, NDC 71286-2071-7

by Central Admixture Pharmacy Services Inc

Reason
Lack of assurance of sterility:
Published
October 11, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Clearasil Rapid Rescue Deep Treatment Pads (Salicylic Acid 2%), packaged in 90-count plastic jar, further packaged in case of 6 jars per case, Distributed by RB Health (US), Parsippany, NJ 07054, NDC 63824-431-90

by RB Health (US) LLC

Reason
Labeling: Label Error on Declared Strength: The incorrect label on the back of the product packaging.
Published
October 4, 2023
Distribution
Nationwide

View recall →

FDA Recall Terminated Historical recordClass III

Eligard (leuprolide acetate) for injectable suspension, 7.5 mg every month, Sterile, Rx Only, Must be reconstituted before use, NDC 62935-753-75, Manufactured by: Tolmar Inc., Fort Collins, CO 80526, For Tolmar Therapeutics Inc., Fort Collins, CO 80526.

by Tolmar, Inc.

Reason
Superpotent Drug - Higher than expected levels of leuprolide acetate in the constituted product.
Published
October 4, 2023
Distribution
Nationwide

View recall →

Data last updated:

Recall records are summarized from official FDA and USDA sources. Notices may be updated, reclassified, terminated, or withdrawn. Always review the linked official notice for the most current instructions. Read the full medical disclaimer.